483 Aspire Pharmaceuticals May 2014

483 Aspire Pharmaceuticals May 2014

Raymond Cheung FDA$119.00 - Available Now

FDA investigators audited the Aspire Pharmaceuticals - Somerset, NJ, United States facility and issued 762 inspectional observations (via FDA 483) on 19 May 2014.

Product details

  • Category: Foods & Cosmetics
  • Number of Observations: 762
  • Inspection end: 19 May 2014
  • Location: Somerset, United States
  • FEI: 3003159106
Add To Cart